📣 VC round data is live. Check it out!
- Public Comps
- Limes Schlosskliniken
Limes Schlosskliniken Valuation Multiples
Discover revenue and EBITDA valuation multiples for Limes Schlosskliniken and similar public comparables like Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes and more.
Limes Schlosskliniken Overview
About Limes Schlosskliniken
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
Founded
N/A
HQ

Employees
200
Website
Sectors
Financials (LTM)
EV
$177M
Valuation Multiples
Start free trialLimes Schlosskliniken Financials
Limes Schlosskliniken reported last 12-month revenue of $69M and EBITDA of $18M.
In the same LTM period, Limes Schlosskliniken generated $18M in EBITDA and $10M in net income.
Revenue (LTM)
Limes Schlosskliniken P&L
In the most recent fiscal year, Limes Schlosskliniken reported revenue of $63M and EBITDA of $16M.
Limes Schlosskliniken is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 25%, and net margin of 14%.
Financial data powered by Morningstar, Inc.
Limes Schlosskliniken Stock Performance
Limes Schlosskliniken has current market cap of $177M, and enterprise value of $177M.
Market Cap Evolution
Limes Schlosskliniken's stock price is $593.41.
Limes Schlosskliniken share price increased by 3.0% in the last 30 days, and by 33.9% in the last year.
Limes Schlosskliniken has an EPS (earnings per share) of $28.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $177M | $177M | 3.1% | 3.0% | 6.9% | 33.9% | $28.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLimes Schlosskliniken Valuation Multiples
Limes Schlosskliniken trades at 2.6x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Limes Schlosskliniken Financial Valuation Multiples
As of June 3, 2026, Limes Schlosskliniken has market cap of $177M and EV of $177M.
Limes Schlosskliniken has a P/E ratio of 17.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Limes Schlosskliniken Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Limes Schlosskliniken Margins & Growth Rates
Limes Schlosskliniken grew revenue by 24% and EBITDA by 31% in the last fiscal year.
In the most recent fiscal year, Limes Schlosskliniken reported gross margin of 85%, EBITDA margin of 25%, and net margin of 14%.
Limes Schlosskliniken Margins
Limes Schlosskliniken Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Limes Schlosskliniken Operational KPIs
Limes Schlosskliniken's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Limes Schlosskliniken's Rule of 40 is 60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Limes Schlosskliniken's Rule of X is 109% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Limes Schlosskliniken Competitors
Limes Schlosskliniken competitors include Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes, Hyperfine, Centrum Medyczne ENEL-MED, Goodwill Pharma, MediClin, Fonar and Atrys Health.
Most Limes Schlosskliniken public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | - | 11.0x | - | |||
| 5.2x | 5.4x | 16.4x | 17.4x | |||
| 1.7x | 1.7x | 7.4x | 7.8x | |||
| 2.7x | - | (5.9x) | - | |||
| 9.0x | 7.5x | (3.5x) | (3.6x) | |||
| 1.0x | - | 7.8x | - | |||
| 3.0x | - | 11.3x | - | |||
| 0.5x | 0.5x | 3.8x | 3.6x | |||
This data is available for Pro users. Sign up to see all Limes Schlosskliniken competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Limes Schlosskliniken
| Where is Limes Schlosskliniken headquartered? | Limes Schlosskliniken is headquartered in Germany. |
| How many employees does Limes Schlosskliniken have? | As of today, Limes Schlosskliniken has over 200 employees. |
| Is Limes Schlosskliniken publicly listed? | Yes, Limes Schlosskliniken is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Limes Schlosskliniken? | Limes Schlosskliniken trades under LIK ticker. |
| When did Limes Schlosskliniken go public? | Limes Schlosskliniken went public in 2019. |
| Who are competitors of Limes Schlosskliniken? | Limes Schlosskliniken main competitors include Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes, Hyperfine, Centrum Medyczne ENEL-MED, Goodwill Pharma, MediClin, Fonar, Atrys Health. |
| What is the current market cap of Limes Schlosskliniken? | Limes Schlosskliniken's current market cap is $177M. |
| What is the current revenue of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months revenue is $69M. |
| What is the current revenue growth of Limes Schlosskliniken? | Limes Schlosskliniken revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Limes Schlosskliniken? | Current revenue multiple of Limes Schlosskliniken is 2.6x. |
| What is the current EBITDA of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months EBITDA is $18M. |
| What is Limes Schlosskliniken's EBITDA margin? | Limes Schlosskliniken's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Limes Schlosskliniken? | Current EBITDA multiple of Limes Schlosskliniken is 9.9x. |
| What is the current FCF of Limes Schlosskliniken? | Limes Schlosskliniken's last 12 months FCF is $10M. |
| What is Limes Schlosskliniken's FCF margin? | Limes Schlosskliniken's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Limes Schlosskliniken? | Current FCF multiple of Limes Schlosskliniken is 17.9x. |
| How many companies Limes Schlosskliniken has acquired to date? | Limes Schlosskliniken hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Limes Schlosskliniken has invested to date? | Limes Schlosskliniken hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Limes Schlosskliniken
Lists including Limes Schlosskliniken
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.